Quality

Quality first!

Patient safety is an absolute priority for UCB.

We implement standards for quality and continuous improvement at each phase of a product’s life cycle, as well as related services.

UCB’s Senior Management is resolutely committed to providing efficacious and safe products worldwide, which are developed, manufactured, distributed and marketed in full compliance with regulatory requirements and UCB’s corporate values. The same high standard of quality is applied worldwide to guarantee patient safety and to satisfy stakeholders’ expectations. This commitment appears in the UCB Global Quality Policy, which is distributed to all employees in all countries and upheld by senior management.

Over the years, UCB has adopted an approach that ensures that the company is optimally prepared, at all times, for regulatory inspections across geographies and disciplines.

In 2010, a total of 50 inspections (2009: 33) were conducted by health authorities worldwide. UCB received no “critical findings” (e.g. FDA Warning Letters) following these inspections. In addition, the inspections did not disrupt our supply chain.

Our formal quality risk management approach facilitates better decision-making and increases the authorities’ confidence in UCB’s ability to deal with potential issues.